AI Buyer Insights:

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Neuren Pharmaceuticals Tech Stack and Enterprise Applications

Neuren Pharmaceuticals Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2017 2017
Neuren Pharmaceuticals Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Egnyte Legacy Egnyte Life Sciences Content Management Content Management n/a 2023 2023
In 2023, Neuren Pharmaceuticals implemented Egnyte Life Sciences as a validated eQMS to meet 21 CFR Part 11 and GxP requirements. The deployment used Egnyte Life Sciences within the Content Management category to provision distinct domains for test, validated GxP workflows, and non GxP collaboration, separating compliance bound content from routine team collaboration. Neuren completed a full eQMS deployment in 12 weeks, configuring document control, validation management, and training record workflows inside the validated GxP domain. Operational scope focused on Australia where the rollout achieved nearly 100% training compliance, with quality and regulatory teams using Egnyte Life Sciences for controlled documents, audit readiness, and formal governance around document approvals and training sign off.
Digital Signing Content Management 2025 2025
Neuren Pharmaceuticals CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Google Legacy Google Tag Manager Tag Management CRM n/a 2022 2022
Neuren Pharmaceuticals IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2014 2014
Content Delivery Network IaaS 2015 2015
Content Delivery Network IaaS 2021 2021
Content Delivery Network IaaS 2025 2025
Content Delivery Network IaaS 2024 2024
Domain Name System (DNS) IaaS 2017 2017
Network Management and Monitoring IaaS 2023 2023
Neuren Pharmaceuticals CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Security (AppSec) CyberSecurity 2022 2022
Secure Email Gateways (SEGs) CyberSecurity 2014 2014
Secure Email Gateways (SEGs) CyberSecurity 2016 2016
Secure Sockets Layer (SSL) CyberSecurity 2014 2014
Secure Sockets Layer (SSL) CyberSecurity 2020 2020
Secure Sockets Layer (SSL) CyberSecurity 2022 2022
Secure Sockets Layer (SSL) CyberSecurity 2023 2023

IT Decision Makers and Key Stakeholders at Neuren Pharmaceuticals

First Name Last Name Title Function Department Email Phone
No data found

Apps Being Evaluated by Neuren Pharmaceuticals Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Neuren Pharmaceuticals IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Neuren Pharmaceuticals digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Neuren Pharmaceuticals Technographics
Neuren Pharmaceuticals is a Life Sciences organization based in Australia, with around 30 employees and annual revenues of $132.0 million.
Neuren Pharmaceuticals operates a diverse technology stack with applications such as Microsoft 365, Egnyte Life Sciences and Google Tag Manager, covering areas like Collaboration, Content Management and Tag Management.
Neuren Pharmaceuticals has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft, Egnyte and Google.
Neuren Pharmaceuticals recently adopted applications including DocuSign eSignature in 2025, Amazon CloudFront in 2025 and Cloudflare CDN in 2024, highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Neuren Pharmaceuticals’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates Neuren Pharmaceuticals’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Neuren Pharmaceuticals technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.